Month: April 2022

NovelStem Announces FDA Pre-Submission and EMA In Vitro Diagnostic Device Filing for Revolutionary Life-Saving, Treatment-Changing Diagnostic Device by 30%-Owned NewStem, Ltd

NewStem is the only company worldwide to develop therapeutics and diagnostics products based on haploid human embryonic stem cell researchJerusalem,...

NeoGenomics Announces That Inivata Liquid Biopsy Subsidiary and Collaborators Have Published Clinical Validation Data for RaDaR(TM) Assay MRD Assay at AACR 2022

Data demonstrates potential of RaDaR to predict clinical response in stage III urothelial cancerFT. MYERS, FL / ACCESSWIRE / April...

error: Content is protected !!